XML 31 R17.htm IDEA: XBRL DOCUMENT v3.24.0.1
Note 10 - Debt and Credit Agreements
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Debt Disclosure [Text Block]

10. DEBT AND CREDIT AGREEMENTS

 

The Company’s outstanding debt balances as of December 31, 2023 and 2022 consisted of the following:

 

  

December 31,

 
  

2023

  

2022

 

Line of credit

 $4,657  $ 

Other notes payable

  1,361   1,094 

Long-term debt

  6,135   7,217 

Total debt

  12,153   8,311 

Less: current maturities

  (5,903)  (1,170)

Long-term debt, net of current maturities

 $6,250  $7,141 

 

As of December 31, 2023, future annual principal payments on the Company’s outstanding debt obligations were as follows:

 

2024

 $5,903 

2025

  1,756 

2026

  1,267 

2027

  1,279 

2028

  1,198 

2029 and thereafter

  750 

Total

 $12,153 

 

Credit Facilities

 

On August 4, 2022, the Company entered into a credit agreement (as amended, the “2022 Credit Agreement”) with Wells Fargo Bank, National Association, as lender (“Wells Fargo”), which replaced its prior credit facility and provided the Company and its subsidiaries with a $35,000 senior secured revolving credit facility (which may be further increased by up to an additional $10,000 upon the request of the Company and at the sole discretion of Wells Fargo) and a $7,578 senior secured term loan (collectively, as amended, the “2022 Credit Facility”). The proceeds of the 2022 Credit Facility are available for general corporate purposes, including strategic growth opportunities. Deferred financing costs related to the 2022 Credit Facility were $359 primarily related to the revolving credit loan, which is net of accumulated amortization of $141, at  December 31, 2023. Deferred financing costs related to the 2022 Credit Facility were $414 which is net of accumulated amortization of $38, at December 31, 2022. These costs are included in the “Other assets” line item of the Company's consolidated financial statements at December 31, 2023 and December 31, 2022. 

 

On February 8, 2023, the Company executed Amendment No. 1 to Credit Agreement and Limited Waiver which waived the Company’s fourth quarter minimum EBITDA (as defined in the 2022 Credit Agreement) requirement for the period ended December 31, 2022, amended the Fixed Charge Coverage Ratio (as defined in the 2022 Credit Agreement) requirements for the twelve-month period ending January 31, 2024 through and including June 30, 2024 and each twelve-month period thereafter, and amended the minimum EBITDA requirements applicable to the twelve-month periods ending March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023.

 

The 2022 Credit Agreement contains customary covenants limiting the Company’s and its subsidiaries’ ability to, among other things, incur liens, make investments, incur indebtedness, merge or consolidate with others or dispose of assets, change the nature of its business, and enter into transactions with affiliates. The initial term of the revolving credit facility matures August 4, 2027. The term loan also matures on August 4, 2027, with monthly payments based on an 84-month amortization.

 

As of December 31, 2023, there was $10,792 of outstanding indebtedness under the 2022 Credit Facility, with the ability to borrow an additional $21,714. As of December 31, 2023, the Company was in compliance with all financial covenants under the 2022 Credit Facility.  As of December 31, 2023, the effective interest rate of the senior secured revolving credit facility was 7.64% and the effective rate of the senior secured term loan was 7.89%. As of December 31, 2022, the effective interest rate of the senior secured revolving credit facility was 6.55% and the effective rate of the senior secured term loan was 6.80%. 

 

Other

 

 The Company has outstanding notes payable for capital expenditures in the amount of $1,361 and $1,094 as of December 31, 2023 and 2022, respectively, with $163 and $88 included in the “Line of credit and current maturities of long-term debt” line item of the Company’s consolidated financial statements as of December 31, 2023 and 2022, respectively. The notes payable have monthly payments that range from $3 to $15 and an interest rate of 6%. The equipment purchased is utilized as collateral for the notes payable. The outstanding notes payable have maturity dates in  September 2028.